Masimo smartSET Receives FDA Clearance to Transform Pulse Oximetry and Elevate Critical Patient Outcomes

Industry-Leading Pulse Oximetry Platform Now Features First-of-Its-Kind Atrial Fibrillation (AFib) Detection with Previously Cleared AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection Designed Together to Deliver Earlier Clinical Insights